Michael J. Comb
  • President / Chief Executive Officer
  • Ph.D., University of Oregon
Dr. Comb acts as CEO but remains the company’s research director in function and heart. Dr. Comb founded Cell Signaling Technology (CST) to provide the research community with tools that he himself sought as a researcher. As Director of the Molecular Neurobiology Lab at Mass General Hospital and Associate Professor of Neuroscience at Harvard Medical School, Dr. Comb’s lab was interested in understanding the neural mechanisms underlying learning and memory. To address these biological questions, Dr. Comb recognized the need to assay intracellular signaling pathways and created the first phospho-specific antibodies (pAKT, pMAPK). Developing innovative technology to provide insight into disease mechanisms is Michael’s passion. At CST, Michael’s research efforts have focused on building antibody technologies and technologies to profile signaling pathways driving cancer. Dr. Comb has published over 60 peer-reviewed publications and is the inventor on numerous patents and patent applications. Dr. Comb holds a B.S. in Chemistry from the University of Massachusetts and a Ph.D. in Chemistry from the University of Oregon.

Selected Publications